跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KISUNLA CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/20ML - PPB Drug Approval Details
Approvals
/
PPB
/
KISUNLA CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/20ML
Approved
STANDARD
KISUNLA CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/20ML
ELI LILLY ASIA, INC.
🇰🇪 Pharmacy and Poisons Board
Approval Date
Oct 15, 2025
Approval ID
e9697982ea8038a5
Company
ELI LILLY ASIA, INC.
Type
Standard
Approval Details
Approval Id
e9697982ea8038a5
Product Name
KISUNLA CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/20ML
Drug Hk Name
KISUNLA CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/20ML
Registration Code
HK-68867
Company Name
ELI LILLY ASIA, INC.
Company Detail Path
/organization/eli-lilly-asia-inc
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2025-10-08
Company Address
RM 3203-06 32/F, CHUBB TOWER WINDSOR HOUSE, 311 GLOUCESTER ROAD, CAUSEWAY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Oct 15, 2025
Approval ID
e9697982ea8038a5
Type
Standard
Back to PPB Approvals